Teva Pharmaceutical Industries Ltd. ADR 1.11% $24.61B ...

Learn More Pharmaceutical giant GSK is pushing the boundaries of what generative AI can achieve in healthcare areas like scientific literature review, genomic analysis and drug discovery.

Pfizer will lower its stake in Haleon from 15 percent to about 7.3% by selling shares worth 2.50 billion pounds ($3.05 ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price target of £14.40. The company’s shares closed today ...

London: GSK plc has announced that the China National Medical Products Administration has approved Nucala (mepolizumab), a ...

(Alliance News) - Pfizer Inc sold 700 million shares in Haleon PLC, as planned, more than halving its remaining stake, placing agent JPMorgan Securities PLC confirmed on Wednesday. Read More ...

GlaxoSmithKline is investing in artificial intelligence (AI) with the hope of radically cutting the time and money needed to develop a drug. It has entered into an alliance with Exscientia, a new ...

Live Well brings health products to the doorsteps of rural Zambians in an innovative partnership between GSK and CARE International ... or much-needed paracetamol? This is the reality for many ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.